SORBITAN MONOOLEATE
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 429.0 | 4.0 | 3 | 6 | 96.0 | 18 | 0.88 |
- CAS
- 1338438
- UNII
- 06XEA2VD56
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 11 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Functions of Sorbitan Monooleate
| Emul - Emulsifier |
Regulatory Status of Sorbitan Monooleate
| Reg - Food additives for which a petition has been filed and a regulation issued. |
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Oral | Capsule | 40MG |
| Oral | Capsule, Soft Gelatin | 153.9MG |
| Oral | Capsule, Soft Gelatin Liquid-Filled | 10MG |
| Oral | Capsule, Sustained Action | 1.7MG |
| Oral | Emulsion | |
| Oral | Solution | 15% |
| Oral | Suspension | |
| Oral | Tablet | 1.7MG |
| Oral | Tablet, Coated | 0.13MG |
| Oral | Tablet, Delayed Action, Enteric Coated | 1.89MG |
| Oral | Tablet, Film Coated | 0.69MG |
| Oral | Tablet, Sustained Action | 7.8MG |
| Oral | Tablet, Sustained Action, Film Coated | 1MG |
| Rectal | Suppository | 22MG |
| Topical | Cream, Augmented | 0.2% |
| Topical | Cream, Emulsion, Sustained Release | 3.5%W/W |
| Topical | Emulsion | 2.5% |
| Topical | Emulsion, Cream | 3.5% |
| Topical | Lotion | 7% |
| Topical | Ointment | |
| Transdermal | Film, Controlled Release |